Prevention and Treatment of Diabetes Using Polyphenols via Activation of AMP-Activated Protein Kinase and Stimulation of Glucagon-like Peptide-1 Secretion

Recent Advances in Polyphenol Research

Volumn 5, Issue , 2016, Pages 206-225

  Tsuda, Takanori ^a  

^a CHUBU UNIVERSITY   (Japan)

Author keywords

AMP activated protein kinase; Anthocyanins; Antidiabetes; Caffeoylquinic acid; Curcumin; Glucagon like peptide 1

Indexed keywords

ANTHOCYANINS; HEALTH; PEPTIDES;

AMP-ACTIVATED PROTEIN KINASE; ANTIDIABETES; CAFFEOYLQUINIC ACIDS; CURCUMIN; GLUCAGON-LIKE PEPTIDE-1;

ENZYME ACTIVITY;

EID: 85017443635     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118883303.ch10     Document Type: Chapter

References (59)

1. Ahn, J., Lee, H., Kim, S., Park, J. and Ha, T. (2008) The anti-obesity effect of quercetin is mediated by the AMPK and MAPK signaling pathways. Biochemical and Biophysical Research Communications, 373, 545-549.
2. Baggio, L.L. and Drucker, D.J. (2007) Biology of incretins: GLP-1 and GIP. Gastroenterology, 132, 2131-2157.
3. Barrajón-Catalán, E., Herranz-López, M., Joven, J. et al. (2014) Molecular promiscuity of plant polyphenols in the management of age-related diseases: far beyond their antioxidant properties. Advances in Experimental Medicine and Biology, 824, 141-159.
4. Baur, J.A., Pearson, K.J., Price, N.L. et al. (2006) Resveratrol improves health and survival of mice on a high-calorie diet. Nature, 444, 337-342.
5. Chuengsamarn, S., Rattanamongkolgulz, S., Luechapudiporn, R., Phisalaphong, C. and Jirawatnotai, S. (2012) Curcumin extract for prevention of type 2 diabetes. Diabetes Care, 35, 2121-2127.
6. Clemmensen, C., Smajilovic, S., Smith, E.P. et al. (2013) Endocrinology, 154, 3978-3983.
7. Collins, Q.F., Liu, H.Y., Pi, J., Liu, Z., Quon, M.J. and Cao, W. (2007) Epigallocatechin-3-gallate (EGCG), a green tea polyphenol, suppresses hepatic gluconeogenesis through 59-AMP-activated protein kinase. Journal of Biological Chemistry, 282, 30143-30149.
8. Czank, C., Cassidy, A., Zhang, Q. et al. (2013) Human metabolism and elimination of the a nthocyanin, cyanidin-3-glucoside: a 13C-tracer study. American Journal of Clinical Nutrition, 97, 995-1003.
9. Dao, T.M., Waget, A., Klopp, P. et al. (2011) Resveratrol increases glucose induced GLP-1 secretion in mice: a mechanism which contributes to the glycemic control. PLoS One, 6, e20700.
10. Dixit, S.S., Wang, T., Manzano, E.J. et al. (2013) Effects of CaMKII-mediated phosphorylation of ryanodine receptor type 2 on islet calcium handling, insulin secretion, and glucose tolerance. PLoS One, 8, e58655.
11. Edfalk, S., Steneberg, P. and Edlund, H. (2008) Gpr40 is expressed in enteroendocrine cells and mediates free fatty acid stimulation of incretin secretion. Diabetes, 57, 2280-2287.
12. Foretz, M., Ancellin, N., Andreelli, F. et al. (2005) Short-term overexpression of a constitutively active form of AMP-activated protein kinase in the liver leads to mild hypoglycemia and fatty liver. Diabetes, 54, 1331-1339.
13. González-Abuín, N., Martínez-Micaelo, N., Margalef, M. et al. (2014a) A grape seed extract increases active glucagon-like peptide-1 levels after an oral glucose load in rats. Food & Function, 5, 2357-2364.
14. González-Abuín, N., Martínez-Micaelo, N., Blay, M., Green, B.D., Pinent, M. and Ardévol, A. (2014b) Grape-seed procyanidins modulate cellular membrane potential and nutrient-induced GLP-1 secretion in STC-1 cells. American Journal of Physiology. Cell Physiology, 306, C485-C492.
15. González-Abuín, N., Martínez-Micaelo, N., Blay, M., Ardévol, A. and Pinent, M. (2014c) Grape-seed procyanidins prevent the cafeteria-diet-induced decrease of glucagon-like peptide-1 production. Journal of Agricultural and Food Chemistry, 62, 1066-1072.
16. Hardie, D.G. (2007) AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy. Nature Reviews Molecular Cell Biology, 8, 774-785.
17. Hardie, D.G. (2008) Role of AMP-activated protein kinase in the metabolic syndrome and in heart disease. FEBS Letters, 582, 81-89.
18. Hardie, D.G. (2011) Sensing of energy and nutrients by AMP-activated protein kinase. American Journal of Clinical Nutrition, 93, 891S-896S.
19. Hawley, S.A., Gadalla, A.E., Olsen, G.S. and Hardie, D.G. (2002) The anti-diabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide-independent m echanism. Diabetes, 51, 2420-2425.
20. Herman, G.A., Bergman, A., Stevens, C. et al. (2006) Effect of single oral doses of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on incretin and plasma glucose levels after an oral glucose t olerance test in patients with type 2 diabetes. Journal of Clinical Endocrinology & Metabolism, 91, 4612-4619.
21. Higuchi, N., Hira, T., Yamada, N. and Hara, H. (2013) Oral administration of corn zein hydrolysate stimulates GLP-1 and GIP secretion and improves glucose tolerance in male normal rats and Goto-Kakizaki rats. Endocrinology, 154, 3089-3098.
22. Hira, T., Mochida, T., Miyashita, K. and Hara, H. (2009) GLP-1 secretion is enhanced directly in the ileum but indirectly in the duodenum by a newly identified potent stimulator, zein hydro-lysate, in rats. American Journal of Physiology-Gastrointestinal and Liver Physiology, 297, G663-G671.
23. Hira, T., Muramatsu, M., Okuno, M. and Hara, H. (2011) GLP-1 secretion in response to oral and luminal palatinose (isomaltulose) in rats. Journal of Nutritional Science and Vitaminology, 57, 30-35.
24. Hirasawa, A., Tsumaya, K., Awaji, T. et al. (2005) Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120. Nature Medicine, 11, 90-94.
25. Iakoubov, R., Izzo, A., Yeung, A., Whiteside, C.I. and Brubaker, P.L. (2007) Protein kinase Czeta is required for oleic acid-induced secretion of glucagon-like peptide-1 by intestinal endocrine L cells. Endocrinology, 148, 1089-1098.
26. Jang, H.J., Kokrashvili, Z., Theodorakis, M.J. et al. (2007) Gut-expressed gustducin and taste receptors regulate secretion of glucagon-like peptide-1. Proceedings of the National Academy of Sciences of the United States of America, 104, 15069-15074.
27. Janssen, S. and Depoortere, I. (2013) Nutrient sensing in the gut: new roads to therapeutics? Trends in Endocrinology & Metabolism, 24, 92-100.
28. Kato, M., Tani, T., Terahara, N. et al. (2015) The anthocyanin delphinidin 3-rutinoside stimulates glucagon-like peptide-1 secretion in murine GLUTag Cell Line via the Ca2+/Calmodulin-dependent kinase II Pathway. PLoS ONE, 10, e0126157.
29. Kim, J.H., Park, J.M., Kim, E.K. et al. (2010) Curcumin stimulates glucose uptake through AMPK-p38 MAPK pathways in L6 myotube cells. Journal of Cellular Physiology, 223, 771-778.
30. Koo, S.H., Flechner, L., Qi, L. et al. (2005) The CREB coactivator TORC2 is a key regulator of f asting glucose metabolism. Nature, 437, 1109-1111.
31. Kurata, R., Adachi, M., Yamakawa, O. and Yoshimoto, M. (2007) Growth suppression of human cancer cells by polyphenolics from sweet potato (Ipomoea batatas L.) leaves. Journal of Agricultural and Food Chemistry, 55, 185-190.
32. Kurimoto, Y., Shibayama, Y., Inoue, S. et al. (2013) Black soybean seed coat extract ameliorates hyperglycemia and insulin sensitivity via the activation of AMP-activated protein kinase in d iabetic mice. Journal of Agricultural and Food Chemistry, 61, 5558-5564.
33. Lan, H., Lin, H.V., Wang, C.F. et al. (2012) Agonists at GPR119 mediate secretion of GLP-1 from mouse enteroendocrine cells through glucose-independent pathways. British Journal of Pharmacology, 165, 2799-2807.
34. Lauffer, L.M., Iakoubov, R. and Brubaker, P.L. (2009) GPR119 is essential for oleoylethanolamide-induced glucagon-like peptide-1 secretion from the intestinal enteroendocrine L-cell. Diabetes, 58, 1058-1066.
35. Lee, S.J., Kim, H.E., Choi, S.E. et al. (2009) Involvement of Ca2+/calmodulin kinase II (CaMK II) in genistein-induced potentiation of leucine/glutamine-stimulated insulin secretion. Molecules and Cells, 28, 167-174.
36. Lehrke, M. and Lazar, M.A. (2005) The many faces of PPARγ. Cell, 123, 993-999.
37. Li, S.K., Zhu, D., Gaisano, H.Y. and Brubaker, P.L. (2014) Role of vesicle-associated membrane protein 2 in exocytosis of glucagon-like peptide-1 from the murine intestinal L cell. Diabetologia, 57, 809-818.
38. Lin, C.L., Huang, H.C. and Lin, J.K. (2007) Theaflavins attenuate hepatic lipid accumulation through activating AMPK in human HepG2 cells. Journal of Lipid Research, 48, 2334-2343.
39. Liu, C.Y., Huang, C.J., Huang, L.H., Chen, I.J., Chiu, J.P. and Hsu, C.H. (2014) Effects of green tea extract on insulin resistance and glucagon-like peptide 1 in patients with type 2 diabetes and lipid abnormalities: a randomized, double-blinded, and placebo-controlled trial. PLoS One, 9, e91163.
40. Lovshin, J.A. and Drucker, D.J. (2009) Incretin-based therapies for type 2 diabetes mellitus. Nature Reviews Endocrinology, 5, 262-269.
41. Minokoshi, Y., Kim, Y.B., Peroni, O.D. et al. (2002) Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature, 415, 339-343.
42. Mochida, T., Hira, T. and Hara, H. (2010) The corn protein, zein hydrolysate, administered into the ileum attenuates hyperglycemia via its dual action on glucagon-like peptide-1 secretion and dipeptidyl peptidase-IV activity in rats. Endocrinology, 151, 3095-3104.
43. Nagai, M., Tani, M., Kishimoto, Y. et al. (2011) Sweet potato (Ipomoea batatas L.) leaves suppressed oxidation of low density lipoprotein (LDL) in vitro and in human subjects. Journal of Clinical and Biochemical Nutrition, 48, 203-208.
44. Nagamine, R., Ueno, S., Tsubata, M. et al. (2014) Dietary sweet potato (Ipomoea batatas L.) leaf extract attenuates hyperglycaemia by enhancing the secretion of glucagon-like peptide-1 (GLP-1). Food & Function, 5, 2309-2316.
45. Ohyama, A., Hosaka, K., Komiya, Y. et al. (2002) Regulation of exocytosis through Ca2+/ATP-dependent binding of autophosphorylated Ca2+/calmodulin-activated protein kinase II to syntaxin 1A. Journal of Neurosciences, 22, 3342-3351.
46. Parker, H.E., Wallis, K., Le Roux, C.W., Wong, K.Y., Reimann, F. and Gribble, F.M. (2012) Molecular mechanisms underlying bile acid-stimulated glucagon-like peptide-1 secretion. British Journal of Pharmacology, 165, 414-423.
47. Phuwamongkolwiwat, P., Hira, T. and Hara, H. (2014) A nondigestible saccharide, fructooligosaccharide, increases the promotive effect of a flavonoid, α-glycosyl-isoquercitrin, on glucagon-like peptide 1 (GLP-1) secretion in rat intestine and enteroendocrine cells. Molecular Nutrition & Food Research, 58, 1581-1584.
48. Reimer, R.A. (2006) Meat hydrolysate and essential amino acid-induced glucagon-like peptide-1 secretion, in the human NCI-H716 enteroendocrine cell line, is regulated by extracellular signal-regulated kinase1/2 and p38 mitogen-activated protein kinases. Journal of Endocrinology, 191, 159-170.
49. Samocha-Bonet, D., Wong, O., Synnott, E.L. et al. (2011) Glutamine reduces postprandial glycemia and augments the glucagon-like peptide-1 response in type 2 diabetes patients. Journal of Nutrition, 141, 1233-1238.
50. Sangle, G.V., Lauffer, L.M., Grieco, A., Trivedi, S., Iakoubov, R. and Brubaker, P.L. (2012) Novel biological action of the dipeptidylpeptidase-IV inhibitor, sitagliptin, as a glucagon-like peptide-1 secretagogue. Endocrinology, 153, 564-573.
51. Scully, T. (2012) Diabetes in numbers. Nature, 485, S2-S3.
52. Shepherd, P.R. and Kahn, B.B. (1999) Glucose transporters and insulin action: implications for i nsulin resistance and diabetes mellitus. New England Journal of Medicine, 341, 248-257.
53. Takikawa, M., Inoue, S., Horio, F. and Tsuda, T. (2010) Dietary anthocyanin-rich bilberry extract ameliorates hyperglycemia and insulin sensitivity via activation of AMP-activated protein kinase in diabetic mice. Journal of Nutrition, 140, 527-533.
54. Takikawa, M., Kurimoto, Y. and Tsuda, T. (2013) Curcumin stimulates glucagon-like peptide-1 secretion in GLUTag cells via Ca2+/calmodulin-dependent kinase II activation. Biochemical and Biophysical Research Communications, 435, 165-170.
55. Tsuda, T. (2015) Possible abilities of dietary factors to prevent and treat diabetes via the stimulation of glucagon-like peptide-1 secretion. Molecular Nutrition & Food Research, 59, 1264-1273.
56. Wedick, N.M., Pan, A., Cassidy, A. et al. (2012) Dietary flavonoid intakes and risk of type 2 diabetes in US men and women. American Journal of Clinical Nutrition, 95, 925-933.
57. Yamauchi, T., Kamon, J., Waki, H. et al. (2001) The mechanisms by which both heterozygous peroxisome proliferator-activated receptorγ (PPARγ) deficiency and PPARγ agonist improve insulin resistance. Journal of Biological Chemistry, 276, 41245-41254.
58. Yamauchi, T., Kamon, J., Minokoshi, Y. et al. (2002) Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nature Medicine, 8, 1288-1295.
59. Zhou, G., Myers, R., Li, Y. et al. (2001) Role of AMP-activated protein kinase in mechanism of metformin action. Journal of Clinical Investigation, 108, 1167-1174.